SYRE Operating Income Growth
Spyre Therapeutics Inc · Operating Income Growth
SYRE Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported5.09%period ending
SYRE TTM Operating Income YoY % (-27.08% → 5.09%)
Year-over-year change
High-resolution chart · PNG
SYRE operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 5.0941% | |
| 5.9354% | |
| -0.4775% | |
| -10.5658% | |
| -35.8419% | |
| 20.9798% | |
| 13.9235% | |
| 10.3567% | |
| 27.6878% | |
| -242.7476% | |
| -185.7987% | |
| -150.463% | |
| -146.5428% | |
| -10.107% | |
| -29.1429% | |
| -26.5919% | |
| -33.1029% | |
| 10.8928% | |
| 19.4303% | |
| 15.6685% | |
| 22.2409% | |
| 1.2619% | |
| -1.4278% | |
| -9.3368% | |
| -32.6038% | |
| -48.882% | |
| -76.7019% | |
| -100.4404% | |
| -96.1554% | |
| -85.4574% | |
| -64.2746% | |
| -38.3273% | |
| -30.705% | |
| -25.0063% | |
| -26.3353% | |
| -30.609% | |
| -42.4525% | |
| -76.4706% | |
| -93.6014% | |
| -93.9232% | |
| -70.9646% | |
| -27.5485% | |
| -27.0777% |